[
  {
    "ts": null,
    "headline": "Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm",
    "summary": "Kroger (NYSE: KR) was one of them.  CFO Todd Foley noted in the company's fourth-quarter earnings call last month that Kroger could be affected somewhat by tariffs.  Foley singled out Kroger's produce business as the area that could be most affected.",
    "url": "https://finnhub.io/api/news?id=9f4ca147670ccb7fa395f305ab39a39a9b5afa041535eddca98d828f6e9818c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743932700,
      "headline": "Worried About Trump's New Tariffs? These 3 U.S. Companies Are Set to Weather the Storm",
      "id": 133738850,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Kroger (NYSE: KR) was one of them.  CFO Todd Foley noted in the company's fourth-quarter earnings call last month that Kroger could be affected somewhat by tariffs.  Foley singled out Kroger's produce business as the area that could be most affected.",
      "url": "https://finnhub.io/api/news?id=9f4ca147670ccb7fa395f305ab39a39a9b5afa041535eddca98d828f6e9818c3"
    }
  },
  {
    "ts": null,
    "headline": "Krystal Biotech: Some Uncertainty, Some Value",
    "summary": "Krystal Biotech: Some Uncertainty, Some Value",
    "url": "https://finnhub.io/api/news?id=b9849bb0d1ee4b4d2393ff1122d8443d15e4a4d0c940c20bcb92934c57448f6f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743928682,
      "headline": "Krystal Biotech: Some Uncertainty, Some Value",
      "id": 133731939,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b9849bb0d1ee4b4d2393ff1122d8443d15e4a4d0c940c20bcb92934c57448f6f"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals: A Look At Their Pain Therapy Program",
    "summary": "Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our recommendation for VRTX stock.",
    "url": "https://finnhub.io/api/news?id=e71e0c482061f2cc3e33b866c2cb06cb57d8cf0414636b550292b4173e5a55f1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743910540,
      "headline": "Vertex Pharmaceuticals: A Look At Their Pain Therapy Program",
      "id": 133730594,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2058537479/image_2058537479.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our recommendation for VRTX stock.",
      "url": "https://finnhub.io/api/news?id=e71e0c482061f2cc3e33b866c2cb06cb57d8cf0414636b550292b4173e5a55f1"
    }
  }
]